【TaiGen Biotech】Company to Participate in SinoPac Securities' Investor Briefing on June 25, 2026
TaiGen Biotech has been invited to attend the investor briefing hosted by SinoPac Securities on June… · 2026-06-23
TaiGen Biotech has been invited to attend the investor briefing hosted by SinoPac Securities on June… · 2026-06-23
PBF Inc. (1760) announced its February 2026 monthly revenue as NT$233 million, a year-on-year decrea… · 2026-02-01
Paolyta Co., Ltd. announced that its board has approved the signing of an authorization agreement fo… · 2026-06-05
PBF announced that the Annual General Meeting held on May 25, 115, approved the lifting of non-compe… · 2026-05-25
PB Pharmaceuticals announced a cash dividend distribution of NT$2 per share, consisting of NT$1.8 fr… · 2026-05-25
PBF held its Annual General Meeting on May 25, 115, approving the 114th-year earnings distribution, … · 2026-05-25
Paion Biotech announced that the Chinese National Medical Products Administration (NMPA) has approve… · 2026-05-21
BaoLing FuJin reported March 2026 revenue of 150 million JPY, a 17.1% increase year-over-year. This … · 2026-03-01
Pao Feng Biotechnology (1760) announced its revenue for May 2026, reaching NT$234 million (234,475 t… · 2026-05-01
Baoling Fujin's board of directors approved the consolidated financial report for the first quarter … · 2026-05-12
Bionime Corporation announced its April 2026 monthly revenue reached TWD 145 million, marking a 7.0%… · 2026-04-01
Bao Ling Fu Jin has announced that its Board of Directors will convene on May 12, 2026, to review an… · 2026-05-04
PBF Biotechs' Nephoxil 500mg Capsule has received approval from China's NMPA for controlling hyperph… · 2026-04-27
BaoLing FuJin reported March 2026 revenue of 150 million JPY, a 17.1% increase year-over-year. This … · 2026-03-01
PBF Inc. (1760) announced its February 2026 monthly revenue as NT$233 million, a year-on-year decrea… · 2026-02-01
Bionime Corporation announced its April 2026 monthly revenue reached TWD 145 million, marking a 7.0%… · 2026-04-01
PBF Biotechs' Nephoxil 500mg Capsule has received approval from China's NMPA for controlling hyperph… · 2026-04-27
Bao Ling Fu Jin has announced that its Board of Directors will convene on May 12, 2026, to review an… · 2026-05-04
Baoling Fujin's board of directors approved the consolidated financial report for the first quarter … · 2026-05-12